HOME >> BIOLOGY >> NEWS
Target for cystic fibrosis drugs found

Biochemists Unravel CF at Most Basic Level

In an advance that promises to speed development of new drugs for cystic fibrosis, Johns Hopkins biochemists have discovered what goes awry inside the cells of CF patients at the most basic level.

It's a folding problem that might be familiar to any home-maker.

In a report in this month's "Biochemistry," the scientists describe the key snafu in cystic fibrosis transmembrane conductance regulator (CFTR), a protein that regulates cellular salt levels and helps ward off bacteria in the lungs. They also offer a new way to remedy it.

Much like, when folding a big bed sheet, one little slip can turn the whole thing into a misshapen mess, a similar thing happens in CF patients, deep within their cells. A genetic slip deletes a tiny but essential slice of CFTR.

This deletion -- of a single amino acid along a chain of nearly 1,500 of them -- occurs at a critical juncture in the twisting, turning protein. So instead of folding into an orderly shape, part of the molecule comes undone.

Molecular traffic cops, which act as chaperones, catch the misshapen proteins and keep them from passing onto the cell's surface, where they are to shuttle chloride ions and other essentials into and out of the cell. The broken protein gets flagged, degraded and recycled.

"The deleted amino acid is like a passport," says Young-Hee Ko, Ph.D., who initiated the project. "Without it, the protein can't travel to the cell membrane, where it is critical for killing bacteria, especially in the lungs." Subsequently, CF patients suffer a lifetime of chronic lung infections and an early death.

The key step in the work was isolating a small, manageable section of the huge CFTR molecule. Because it would have taken years to decode the structure of the whole protein in the lab, the researchers saved time by synthesizing a small section, just 26 amino acids long. They also made a 25-amino acid version that was missi
'"/>

Contact: Brian Vastag
bvastag@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
23-Jun-1999


Page: 1 2 3

Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
3. Targeted therapy knocks out pediatric brain cancer in mice
4. Targeted therapy for lung cancer patients shows promise in extending lives
5. Targeting hard-to-kill fungal infections
6. Avoid bad memories: Targeting genes and drugs
7. Targeting transcription: New insights into turning genes on
8. Targeted immunotherapy eradicates cancer in mice
9. Targeted radiation to liver tumors spares tissue, improves quality of life
10. Targeting enzymes that immortalize cancer cells: if you cant turn them off, round them up
11. Target cells found to play active role in synapse formation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Target for cystic fibrosis drugs found

(Date:6/16/2013)... group together and move around the body called ,chase ... by scientists at UCL. , Published in Nature ... that occurs when cancer cells interact with healthy cells in ... that cancer cells recruit healthy cells and use them to ... how it could be controlled to design new therapies against ...
(Date:6/15/2013)... drug approved in Europe to treat osteoporosis has now ... cells, even in cancers that have become resistant to ... study. , The findings, presented June 15, 2013, at ... that the drug bazedoxifene packs a powerful one-two punch ... cell growth, but also flags the estrogen receptor for ...
(Date:6/14/2013)... will collaborate with researchers from Oklahoma State University, ... of Tulsa to advance understanding of how socio-ecological ... and variability in the state. , Oklahoma ... $20 million National Science Foundation Experimental Program to ... innovative research over the next five years. ...
Breaking Biology News(10 mins):'Chase and run' cell movement mechanism explains process of metastasis 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3
(Date:6/18/2013)... June 18, 2013 The human skin is ... as an important human body part. Similar to the liver, ... order to function, repair and grow. Recent reports from the ... supplements, is just as important as other life supporting organs. ... aid in skin cell reproduction, increase the appearance of skin, ...
(Date:6/18/2013)... WILMINGTON, Delaware , June 18, 2013 /PRNewswire/ ... to announce the release of the HELM biomolecular ... permissive open source MIT licence. HELM ... of a wide range of biomolecules (e.g. proteins, ... render existing small-molecule and sequence-based informatics methodologies impractical ...
(Date:6/18/2013)... The "Bioinformatics Market By Sector (Molecular Medicine, Agriculture, Research ... Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Global Forecasts ... and Opportunities in North America , ... Rest of World. Browse , ... 364 Pages and an in-depth Table ...
(Date:6/18/2013)... 18, 2013 Research ... the addition of the report " DNA ... to their offering.      (Logo: ... basics of human genome variations, development of ... and small sequencers are described as well ...
Breaking Biology Technology:Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
Cached News: